May 5, 2023, 16:29 PM by

MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, has closed a £5 million (US$6.2 million) seed funding extension round to build its precision therapeutics discovery platform for metabolic syndrome-related medical conditions.

May 5, 2023, 16:29 PM by

FDB Vela™ Leader to Share Vision for Vastly Reducing Fill Times for Specialty Drug ePrescribing at NCPDP Annual Conference

May 5, 2023, 16:29 PM by

The RSA Group, a leading life sciences executive search firm, has published the latest of its Talent Equity® Reports: No turning back – an analysis of the hybrid working models that have emerged from the pandemic and how they have enabled positive changes to leadership, team dynamics and recruitment and retention of talent in the life science sector.

May 5, 2023, 16:29 PM by

BOC Sciences, one of the front-runners in chemical material manufacturing and custom services for the full drug product lifecycle, today reported strong growth over the past year in its expanded contract development and manufacturing (CDMO) platform.

May 5, 2023, 16:29 PM by

BOC Sciences' radiochemists work closely with the worldwide drug compound research teams to deliver high-quality stable isotope labeled products as well as consulting and tailor-made services.

May 5, 2023, 01:00 AM by User Not Found

Bio-IT World | Next-generation sequencing (NGS) has revolutionized molecular biology and served as a universal tool for many research avenues across the spectrum of biology. With the NGS market expanding, three key barriers—time, cost, and expertise—are holding back the potential of NGS and the full impact it could have on society, diagnostics, and precision medicine.

May 4, 2023, 13:24 PM by User Not Found

Bio-IT World | At Pfizer, AI plays a key role in every step of the drug discovery process, Anastasia Christianson, Global Head of AI, ML, Analytics, and Data at Pfizer, tells Bio-Team co-founder Stan Gloss on the latest episode of the Trends from the Trenches podcast. Christianson will be the opening keynote at the 2023 Bio-IT World Conference & Expo, May 16-18, 2023, in Boston.

May 3, 2023, 01:00 AM by User Not Found

Bio-IT World | Up to now, mouse avatars haven’t proven to be particularly good tools for forecasting treatment response in human cancer patients. But new models being generated by an international team of researchers are expected to be far more predictive of what is going to happen with different cohorts of clinical trial participants.

Apr 27, 2023, 01:00 AM by User Not Found

Bio-IT World | Ginkgo Bioworks acquires an adeno-associated virus capsid discovery and engineering platform; Oxford Nanopore Technologies and bioMérieux SA have teamed up bring nanopore sequencing to the infectious disease diagnostics market, and the emergency of Large Language Models ops. Plus, new products from Metabolon, Cytiva, Vizgen, Agilent, and more.

Apr 26, 2023, 01:00 AM by User Not Found

Bio-IT World | Research autopsies are nothing new—the use of post-mortem tissues for cancer research has been ongoing since the end of the nineteenth century—but the Cancer Research UK-sponsored PEACE (posthumous evaluation of advanced cancer environment) study stands apart by virtue of its scope and scale. The pan-cancer initiative intends to enroll 500 patients across the country in hopes of understanding cancer evolution, drug resistance and why patients die of their disease.

Apr 25, 2023, 11:39 AM by

CSHL scientists have discovered that a protein called BRD8 goes out of control in glioblastoma, paralyzing P53. The discovery could help turn this deadly cancer into a treatable disease.

Apr 25, 2023, 11:39 AM by

Apr 25, 2023, 11:39 AM by

Apr 25, 2023, 11:39 AM by

Apr 25, 2023, 11:39 AM by

Form Bio is a cutting-edge research and discovery platform for individuals and enterprises in life sciences. With an accessible, comprehensive and collaborative platform, Form Bio empowers scientists to efficiently and effectively harness the proliferation of data and computing power that has transformed the science of discovery. Form offers end-to-end integration of the discovery process with intuitive and easy-to-use software applications, combined with an open and adaptable collaborative environment. For more information on Form Bio, visit www.formbio.com

Apr 25, 2023, 11:39 AM by

Form Bio, the provider of advanced computational life sciences technology today announced it has joined the PacBio Compatible program. As part of the program, the Form Bio platform has been verified as compatible with PacBio’s HiFi sequencing solutions, empowering corporate and academic research teams with a dramatically streamlined path from HiFi read data to breakthrough insights.

Apr 25, 2023, 11:39 AM by

New panel leverages Anchored Multiplex PCR (AMP™) chemistry and Archer Analysis to detect fusions, splice variants and more, enabling downstream application of precision medicine

Apr 25, 2023, 11:38 AM by

Innovative Application of Artificial Intelligence and Machine Learning Gives Healthcare Organizations Additional Capabilities to Stop Threat Actors by Enabling Them to Make Better Cyber Risk Decisions

Apr 25, 2023, 11:38 AM by

Elvin Wagenblast, PhD, of The Tisch Cancer Institute at Mount Sinai, received a CureSearch Young Investigator Award to develop a better understanding of AML in order to guide treatment for patients where standard chemotherapy is ineffective. The study is investigating how a normal blood stem cell can become cancerous. Dr. Wagenblast’s team is using state-of-the-art genome editing to understand vulnerabilities of the disease like never before.

Apr 25, 2023, 11:38 AM by

Domainex is honoured to announce it has received a King’s Award for Enterprise: International Trade 2023.